Objective: to explore the practical efficacy of minimally invasive McKeown recurrent laryngeal nerve lymph node dissection in clinical practice. Methods: a total of 116 esophageal cancer patients (all admitted to our ...Objective: to explore the practical efficacy of minimally invasive McKeown recurrent laryngeal nerve lymph node dissection in clinical practice. Methods: a total of 116 esophageal cancer patients (all admitted to our hospital from March 2019 to March 2022) were randomly selected for this analysis. They were randomly divided into observation group and control group, with 58 cases. The control group underwent routine para-recurrent recurrent nerve lymph node dissection by minimally invasive McKeown esophagectomy, and the observation group performed bilateral para-recurrent nerve lymph node dissection. The surgical indexes, pathological differentiation and stage degree, postoperative complications, lymph node dissection times, the recurrent laryngeal nerve lymph node metastasis rate and tumor distribution were observed and compared between the two groups. Results: the corresponding intraoperative bleeding amount, the operation time and the hospital stay time were all lower than the control group (P < 0.05). There was no significant difference in the degree of postoperative pathological differentiation and stage results between the two groups (P > 0.05). The overall incidence of postoperative complications showed that the observed group was significantly lower than that in the control group (P < 0.05).The number of corresponding lymph node dissection in the observed group was higher than that of the control group, and the rate of recurrent laryngeal nerve lymph node metastasis was lower than that of the control group (P < 0.05). The results of the tumor distribution showed no significant difference between the two groups (P > 0.05). Conclusion: minimally invasive McKeown esophagectomy has significant efficacy and high feasibility.展开更多
文摘Objective: to explore the practical efficacy of minimally invasive McKeown recurrent laryngeal nerve lymph node dissection in clinical practice. Methods: a total of 116 esophageal cancer patients (all admitted to our hospital from March 2019 to March 2022) were randomly selected for this analysis. They were randomly divided into observation group and control group, with 58 cases. The control group underwent routine para-recurrent recurrent nerve lymph node dissection by minimally invasive McKeown esophagectomy, and the observation group performed bilateral para-recurrent nerve lymph node dissection. The surgical indexes, pathological differentiation and stage degree, postoperative complications, lymph node dissection times, the recurrent laryngeal nerve lymph node metastasis rate and tumor distribution were observed and compared between the two groups. Results: the corresponding intraoperative bleeding amount, the operation time and the hospital stay time were all lower than the control group (P < 0.05). There was no significant difference in the degree of postoperative pathological differentiation and stage results between the two groups (P > 0.05). The overall incidence of postoperative complications showed that the observed group was significantly lower than that in the control group (P < 0.05).The number of corresponding lymph node dissection in the observed group was higher than that of the control group, and the rate of recurrent laryngeal nerve lymph node metastasis was lower than that of the control group (P < 0.05). The results of the tumor distribution showed no significant difference between the two groups (P > 0.05). Conclusion: minimally invasive McKeown esophagectomy has significant efficacy and high feasibility.
